+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

T ₁-Weight Magnetic Resonance Imaging Performances of Iron Oxide Nanoparticles Modified with a Natural Protein Macromolecule and an Artificial Macromolecule



T ₁-Weight Magnetic Resonance Imaging Performances of Iron Oxide Nanoparticles Modified with a Natural Protein Macromolecule and an Artificial Macromolecule



Nanomaterials 9(2)



To optimize the iron oxide nanoparticles as T₁-weight contrast for in vivo magnetic resonance imaging (MRI), numbers of macromolecule ligands have been explored with considerable effort. However, reports refer to the comparison of the T₁-weight contrast performances of iron oxide nanoparticles modified with natural and artificial macromolecule ligands are still limited. In this work, we used a typical natural protein macromolecule (bovine serum albumin, BSA) and an artificial macromolecule (poly(acrylic acid)-poly(methacrylic acid), PMAA-PTTM) as surface ligands to fabricate Fe₃O₄-BSA and Fe₃O₄-PMAA-PTTM nanoparticles with similar size and magnetization by the coprecipitation method and compared their MRI performances. In vitro and in vivo experiments revealed that Fe₃O₄-BSA with lower cytotoxicity exhibited higher r₂/r₁ ratio in solution and darkening contrast enhancement for liver and kidney sites of mice under T₁-weight imaging, while Fe₃O₄-PMAA-PTTM displayed much lower r₂/r₁ ratio in solution and brighter contrast enhancement for liver and kidney sites. These remarkably different MRI behaviors demonstrated that the surface ligands play an important role for optimizing the MRI performance of Fe₃O₄ nanoparticles. We expect these results may facilitate the design of macromolecule ligands for developing an iron oxide⁻based T₁-weight contrast agent.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446200

Download citation: RISBibTeXText

PMID: 30704072

DOI: 10.3390/nano9020170


Related references

Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery. Theranostics 3(12): 986-1003, 2014

(Carboxymethyl)chitosan-modified superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of stem cells. Acs Applied Materials and Interfaces 1(2): 328-335, 2010

3-Aminopropylsilane-modified iron oxide nanoparticles for contrast-enhanced magnetic resonance imaging of liver lesions induced by Opisthorchis felineus. International Journal of Nanomedicine 11: 4451-4463, 2016

Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties. CytoTherapy 13(8): 962-975, 2011

Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T 1 -Weighted Magnetic Resonance Imaging and Chemotherapy. Acs Nano 11(11): 10992-11004, 2017

Macromolecule-macromolecule interaction in drug distribution. IV. Molecular weight dependency in the interaction of fractionated [3H]heparin with plasma proteins. Biological & Pharmaceutical Bulletin 19(2): 287-290, 1996

Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. Langmuir 23(8): 4583-4588, 2007

Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magnetic Resonance in Medicine 35(5): 633-639, 1996

Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent. Bulletin of Experimental Biology and Medicine 162(6): 808-811, 2017

Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content. International Journal of Hyperthermia 30(3): 192-200, 2014

Application of magnetic iron oxide nanoparticles in magnetic resonance / photothermal dual-modal imaging. Yao Xue Xue Bao 52(3): 481-487, 2018

RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia. Journal of Biomaterials Applications 28(7): 1051-1059, 2014

Concurrent dual contrast for cellular magnetic resonance imaging using gadolinium oxide and iron oxide nanoparticles. International Journal of Molecular Imaging 2012: 230942, 2012

A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quantitative Imaging in Medicine and Surgery 7(1): 88-122, 2017

Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging. Chemical Communications 47(32): 9221-9223, 2011